![](/img/cover-not-exists.png)
Phase IB study of methoxymorpholinodoxorubicin (PNU 152243; FCE 23762) administered in a 3 or 4 weekly schedule
de Takats, P.G, Dunlop, D., Kaye, S.B., Fyfe, D.W., Baker, P., Pacciarini, M.A., Valota, O., Kerr, D.J.Volume:
33
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(97)86043-1
Date:
September, 1997
File:
PDF, 392 KB
english, 1997